BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 47 filers reported holding BCLS ACQUISITION CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,885,000 | +1.2% | 487,500 | 0.0% | 0.58% | +3.0% |
| Q2 2022 | $4,826,000 | +0.3% | 487,500 | 0.0% | 0.57% | +21.2% |
| Q1 2022 | $4,812,000 | +0.7% | 487,500 | 0.0% | 0.47% | +23.2% |
| Q4 2021 | $4,778,000 | -1.6% | 487,500 | 0.0% | 0.38% | +25.9% |
| Q3 2021 | $4,856,000 | -5.4% | 487,500 | 0.0% | 0.30% | -10.4% |
| Q2 2021 | $5,133,000 | -0.4% | 487,500 | 0.0% | 0.34% | +15.1% |
| Q1 2021 | $5,153,000 | -5.1% | 487,500 | 0.0% | 0.29% | -14.4% |
| Q4 2020 | $5,431,000 | – | 487,500 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,912,000 | 3.21% |
| COMMODORE CAPITAL LP | 250,000 | $2,643,000 | 1.05% |
| Samsara BioCapital, LLC | 300,000 | $3,171,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 687,900 | $7,271,000 | 0.56% |
| Asymmetry Capital Management, L.P. | 82,377 | $871,000 | 0.45% |
| First Trust Capital Management L.P. | 191,272 | $2,022,000 | 0.40% |
| Altium Capital Management LP | 100,000 | $1,057,000 | 0.29% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $5,153,000 | 0.29% |
| RA Capital Management | 1,250,000 | $13,213,000 | 0.20% |
| Boxer Capital, LLC | 500,000 | $5,285,000 | 0.18% |